Go back
“ARCHIMED’s uniqueness lies in our entrepreneurial, business-builder mindset. On top of focusing on financial engineering, we are also pouring our energy into business development and the growth of each company beyond their exit horizon. This mindset allows us to think in terms of mid-term value creation rather than short term financial metrics, earning trust from the management companies and creating true business partners who share the same vision.”
André-Michel Ballester is a Managing Partner. He is leading the ARCHIMED MedTech Sector. André-Michel has a long-standing relationship with other ARCHIMED Partners.
André-Michel joined ARCHIMED in 2017 as a Strategic Partner. Prior to this, he was working with ARCHIMED as a MedTalent®. He became a Partner in 2018.
He has accrued over 30 years of experience in the healthcare sector, through CEO and non-executive Director positions in European and US MedTech companies, such as LivaNova (formed through the merger of Cyberonics and Sorin Group), Edwards Lifesciences and Baxter.
Over the course of his career, André-Michel has overseen the integration of more than 15 acquisitions and has successfully led the IPOs of three companies as either CEO or Board Member.
André-Michel currently serves as a non-executive Director in Italian manufacturer of cardiology devices, Cardioline, French testing service provider, CARSO, US based Contract Research Organization (CRO), NAMSA, US based medical device solutions provider, Natus, and as a Chairman of the Board (non-executive) of Spanish manufacturer of APIs, SUANFARMA.
André-Michel is a member of the healthcare taskforce of the Institut Montaigne, a leading independent think tank, and founded the professional association “MedTech in France”.
PORTFOLIO COMPANIES
